Ifp Advisors, Inc Cellectar Biosciences, Inc. Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$3.5 - $6.9 $17 - $34	5 New	5 $1,000
Q2 2022 Aug 12, 2022	SELL	$3.5 - $6.9 $17 - $34	-5 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$4.6 - $7.8 $23 - $39	5 New	5 $0
Q4 2019 Jan 17, 2020	SELL	$10.6 - $24.1 $53 - $120	-5 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$20.0 - $24.6 $100 - $123	5 New	5 $0
Q1 2019 May 15, 2019	SELL	$15.8 - $28.5 $474 - $855	-30 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$21.9 - $79.0 $657 - $2,370	30 New	30 $0

Ticker CLRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 6,114,290
Market Cap $13M
Description
Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's ma...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.